Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload July 24, 2026 9:00 ...
On July 16, 2026, the FDA approved the world's first oral PCSK9 inhibitor. Lipfendra (generic name: enlicitide), a once-daily 20mg tablet from Merck (MSD outside the U.S. and Canada). It is indicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results